Avomeen Blog

Wednesday, September 25, 2013

When Dr. Shri Thanedar, CEO of Avomeen Analytical Services,
heard news of the recent Johnson & Johnson recall, he had a word of advice
to offer. The company just recently announced the recall of Motrin Infant Drops
due to the possibility that the medication may be contaminated with plastic
particles. Dr. Thanedar advised the following:

“The first practices any company should introduce are
ways to protect their products. Preventative measures should be put in place to
avoid product defect or contamination. However, it is also imperative to know
what steps to take if a product failure should occur. Johnson & Johnson
responsibly removed the medication for sale that had even a chance of
contamination. The question for them now is – what’s next?”

Dr. Thanedar suggests J&J should consult a laboratory
that can conduct both a failure analysis study as well as provide method
development and validation. These services can assist Johnson & Johnson in
determining the precise origin of the contaminant as well as identifying any
future issues they might have. Mitigating risk before it happens is the best
defense any company can have against recalls. However, issues do arise and that
is when having the right resources makes all the difference.

Avomeen Analytical Services is well versed in testing for
product defects. Using techniques such as FT-IR, SEM/EDXA, GC/MS and LC/MS, contaminants
in formulated products can be precisely isolated and identified. With services
ranging from comprehensive deformulation to litigation support we are the
resource for even the most difficult cases.